FR66979 requires reductive activation to cross-link DNA efficiently
- 1 December 1994
- journal article
- Published by Elsevier in Tetrahedron Letters
- Vol. 35 (52) , 9669-9672
- https://doi.org/10.1016/0040-4039(94)88355-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Covalent Structure of the DNA-DNA Interstrand Cross-Link Formed by Reductively Activated FR66979 in Synthetic DNA DuplexesJournal of the American Chemical Society, 1994
- Determination of DNA cross-linking sequence specificity of FR66979: Observations on the mode of action of the FR900482 class of anti-tumor compoundsTetrahedron Letters, 1993
- DNA interstrand cross-linking by reductively activated FR900482 and FR66979Journal of the American Chemical Society, 1993
- DNA cross-linking studies on FR900482 : observations on the mode of activationTetrahedron Letters, 1992
- Synthetic approaches toward FR-900482. I. Stereoselective synthesis of a pentacyclic model compoundTetrahedron Letters, 1989
- A new antitumor antibiotic, FR-66979.The Journal of Antibiotics, 1989
- A new antitumor antibiotic, FR-900482: V. Interstrand DNA-DNA cross-links in L1210 cells.The Journal of Antibiotics, 1988
- Isolation and Structure of a Covalent Cross-Link Adduct Between Mitomycin C and DNAScience, 1987